Similar to the results of other experiences, the level of the therapeutic line showed a nearly significant relationship with the PFS value, since first-line treatment with checkpoint inhibitors was associated with better outcome than those of later applications [ 19 ].
← all excerpts
Therapeutic and Adverse Effect of Anti-PD1 Immunotherapy in Melanoma: A Retrospective, Single-Institute Study of 222 Patients.
1
—
—